Please wait...
Börse Frankfurt

Drägerwerk AG & Co. KGaA Vz

Equity, ISIN DE0005550636, WKN 555063, DRW3

This section contains not only general information but also information dealing with the company's follow-up obligations as part of the membership in a certain transparency standard at Börse Frankfurt, FWB, the Frankfurt Stock Exchange. This mandatory information is marked with an asterisk. Learn more about what information is required depending on transparency standard and asset class on


Address Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Phone +49 (0)451 882-0
Fax +49 (0)451 882-2080

About the Company

Dräger is an international leader in the fields of medical and safety technology. Founded in Lübeck in 1889, Dräger has grown into a worldwide, DAX-listed enterprise in its fifth generation as a family-run business. Our long-term success is predicated on a value-oriented corporate culture with four central strengths: close collaboration with our customers, the expertise of our employees, continuous innovation and outstanding quality.

'Technology for Life' is our guiding principle and our mission. Wherever they are deployed - in clinical settings, industry, mining or emergency services - Dräger products protect, support and save lives.

Dräger Safety offers its customers complete hazard management solutions with a special focus on personal safety and protecting production facilities. The Safety division's current portfolio includes stationary and mobile gas detection systems, respiratory protection, firefighting equipment, professional diving gear, and alcohol and drug-testing instruments.

The Medical division's product range covers anesthesia workstations, ventilation equipment for intensive and home care, emergency and mobile ventilation units, warming therapy equipment for infants, patient monitoring equipment, IT solutions and gas management systems.

Dräger has nearly 13,500 employees worldwide and is present in over 190 countries around the globe. The Group maintains sales and service organizations in over 50 countries. Dräger's development and production facilities are located in Germany, Great Britain, Sweden, South Africa, the United States, Brazil, Czech Republic and China.

Corporate Information

Established 1889
Transparency Standard Prime Standard
Market Segment Regulated Market
End of Business Year 31/12/
Accounting Standard IFRS
Total Capital Stock € 45,465,600.00
Admission Date 01/01/1979
Executive Board Stefan Dräger (Chairman), Gert Hartwig Lescow, Toni Schrofner
Supervisory Board Dr. Nikolaus Schweickart (Chairman), Siegfried Kasang* (Vice Chairman), Daniel Friedrich*, Dr. Thorsten Grenz, Uwe Lüders, Bernd Mußmann*, Walter Neundorf*, Regina Pawils, Jürgen Peddinghaus, Dr. Klaus Rauscher, Thomas Rickers*, Ulrike Tinnefeld*, Dr. Reinhard Zinkann

*Employee Representative
Period Title Download Comment Comment
01/01/2015 till 30/06/2015 Six-month statement PDF

Please note: The report titles may differ from the denominations in the rules and regulations for Frankfurt Wertpapierbörse (FWB®, the Frankfurt Stock Exchange).

Shareholder Structure Bearer shares without par value ISIN DE0005550602

Shareholder Current Shares in %
Dr. Heinrich Dräger GmbH 67.19


Last Payment Date Dividend Cycle Amount ISIN
04/05/2015 Annually € 1.33 DE0005550602
12/05/2014 Annually € 0.77 DE0005550602
12/05/2014 Annually € 0.83 DE0005550636
06/05/2013 Annually € 0.86 DE0005550602
06/05/2013 Annually € 0.92 DE0005550636
07/05/2012 Annually € 0.13 DE0005550602
07/05/2012 Annually € 0.19 DE0005550636
09/05/2011 Annually € 1.13 DE0005550602
09/05/2011 Annually € 1.19 DE0005550636
10/05/2010 Annually € 0.34 DE0005550602
Results 1 - 10 of 27

IPO Company Data

No data available on this website.

* Please note: Companies may address supplementary questions regarding the submission of mandatory data marked with an * by sending an e-mail to:, phone: +49-(0) 69-2 11-1 31 87.